Considering the B- and T-cell lymphoma cell lines exposed to both PI3K inhibitors (n = 41), the correlation between AUC values and PIK3CD mRNA expression was stronger for IOA-244 (R2 = 0.19, P = 0.005), than for idelalisib (R2 = 0.11, P = 0.033; Supplementary Fig. S3A and S3B). This evidence concerns the gene PIK3CD and T-cell non-Hodgkin lymphoma.